News summary

Traded: Venture Capital 🦄 on Instagram: "Vesalius Longevity Labs (CSE: VLAB) (@Vesalius_Longevity), a longevity and regenerative health platform focused on peptides, biologics, and preventative healthcare, raised $25 million. Headquartered in Scottsdale, Arizona, and Vancouver, British Columbia, the company operates a proprietary ecosystem that connects healthcare providers with compliant pharmacies and provides access to therapies, education, and partnerships. Vesalius plans to begin manufacturing its own Peptual® “Made-in-the-USA” peptide APIs to supply compounding pharmacies domestically and internationally. The raise included investors David Adelman, Harvey Spevak, Kevin Mayer, David Blitzer, Dana White, Gary Brecka and Brigham Buhler. James McRoberts founded the company. FUN FACTS: The company will use the capital to expand its sales team, enter new global markets, and meet growing demand for safe, regulated access to longevity therapies. FOUNDER: James McRoberts INVESTORS: David Adelman (@DavidAdelman), Harvey Spevak (@hspevak), Kevin Mayer (@KevinMayer), David Blitzer, Dana White (@DanaWhite), Gary Brecka (@GaryBrecka), Brigham Buhler (@brigham.buhler) AMOUNT: $25,000,000 HQ: Scottsdale, Arizona & Vancouver, British Columbia #VentureCapital #VesaliusLongevityLabs #TradedPartner #TradedVC"

Source: traderVC • Published: 19 Nov 2026, 16:46

Summarized by Masters of Longevity from traderVC.

Vesalius Longevity Labs raised $25 million to scale its longevity platform.

Traded: Venture Capital 🦄 on Instagram: "Vesalius Longevity Labs (CSE: VLAB) (@Vesalius_Longevity), a longevity and regenerative health platform focused on peptides, biologics, and preventative healthcare, raised $25 million. Headquartered in Scottsdale, Arizona, and Vancouver, British Columbia, the company operates a proprietary ecosystem that connects healthcare providers with compliant pharmacies and provides access to therapies, education, and partnerships. Vesalius plans to begin manufacturing its own Peptual® “Made-in-the-USA” peptide APIs to supply compounding pharmacies domestically and internationally. The raise included investors David Adelman, Harvey Spevak, Kevin Mayer, David Blitzer, Dana White, Gary Brecka and Brigham Buhler. James McRoberts founded the company. FUN FACTS: The company will use the capital to expand its sales team, enter new global markets, and meet growing demand for safe, regulated access to longevity therapies. FOUNDER: James McRoberts INVESTORS: David Adelman (@DavidAdelman), Harvey Spevak (@hspevak), Kevin Mayer (@KevinMayer), David Blitzer, Dana White (@DanaWhite), Gary Brecka (@GaryBrecka), Brigham Buhler (@brigham.buhler) AMOUNT: $25,000,000 HQ: Scottsdale, Arizona & Vancouver, British Columbia #VentureCapital #VesaliusLongevityLabs #TradedPartner #TradedVC"
Key Takeaways
  • Multiple high-profile investors are backing the financing round.
  • The company is planning domestic peptide API manufacturing.
  • Expansion is aimed at growing sales and entering global markets.
Read the full article at traderVC ↗

Continue exploring

Recommended MoL Picks

MoL PickCan Doctors Be Trained for the Longevity Era?A new global survey suggests that healthy longevity medicine education can change how physicians think and talk about ageing. But the evidence also highlights how much work remains before a rapidly growing field becomes routine clinical care.MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.